Krebs Biochemicals & Industries reports standalone net loss of Rs 2.48 crore in the June 2026 quarter

Sales rise 27.37% to Rs 6.98 crore

Net Loss of Krebs Biochemicals & Industries reported to Rs 2.48 crore in the quarter ended June 2026 as against net loss of Rs 5.32 crore during the previous quarter ended June 2025. Sales rose 27.37% to Rs 6.98 crore in the quarter ended June 2026 as against Rs 5.48 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	6.98	5.48	27
OPM %	11.89	-37.96	-
PBDT	-0.89	-3.72	76
PBT	-2.48	-5.32	53
NP	-2.48	-5.32	53

Powered by Capital Market - Live News